Strengthening its commitment to promoting good manufacturing practices, the Indian Pharmaceutical Alliance (IPA) recently organised 8th Advanced Good Manufacturing Practices (GMP) Workshop. The workshop took place virtually on 3-4 October 2023, with 20+ subject matter experts, industry leaders and global regulators from USFDA, MHRA, CDSCO.

Over the years, the main purpose of the workshop has consistently been to facilitate the sharing of knowledge and the development of capabilities among Indian pharmaceutical companies, enabling them to embrace globally acknowledged manufacturing practices.

The 8th edition of the Advanced GMP workshop served as a forum where manufacturers, regulators, and subject matter experts came together to engage in meaningful discussions and deliberate on strategies for advancing Manufacturing and Quality Excellence within the pharmaceutical industry. 

The event witnessed the active participation of more than 1500 industry and academic professionals from around the world. They engaged in informative sessions covering a broad spectrum of topics, including Quality Culture, Data Integrity within the context of Quality, Capacity Building, Next-Generation Operations, and India's journey towards quality leadership.

Additionally, the workshop delved into the transformative potential of Generative AI in the pharmaceutical sector, offering insights into the future of quality practices. Moreover, the discussions at the 8th Advanced GMP Workshop not only deepened the understanding of crucial issues but also facilitated the sharing of best practices in key areas of Quality.